These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8446129)

  • 41. Activity-dependent hyperpolarization and conduction block in chronic inflammatory demyelinating polyneuropathy.
    Cappelen-Smith C; Kuwabara S; Lin CS; Mogyoros I; Burke D
    Ann Neurol; 2000 Dec; 48(6):826-32. PubMed ID: 11117538
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Compound sensory action potential in normal and pathological human nerves.
    Krarup C
    Muscle Nerve; 2004 Apr; 29(4):465-83. PubMed ID: 15052613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered thermal sensitivity in injured and demyelinated nerve. A possible model of temperature effects in multiple sclerosis.
    Davis FA; Jacobson S
    J Neurol Neurosurg Psychiatry; 1971 Oct; 34(5):551-61. PubMed ID: 5122383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. "Pseudo-conduction block" in a patient with vasculitic neuropathy.
    Sandbrink F; Klion AD; Floeter MK
    Electromyogr Clin Neurophysiol; 2001 Jun; 41(4):195-202. PubMed ID: 11441636
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ratios of nerve conduction parameters in proximal to distal limbs remain constant through the second to the eighth decades.
    Kurokawa K; Tanaka E; Yamashita H; Kohriyama T; Mimori Y; Nakamura S
    Electromyogr Clin Neurophysiol; 1998; 38(3):169-76. PubMed ID: 9637943
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome.
    Viala K; Renié L; Maisonobe T; Béhin A; Neil J; Léger JM; Bouche P
    Brain; 2004 Sep; 127(Pt 9):2010-7. PubMed ID: 15289267
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences in potentials and excitability properties in simulated cases of demyelinating neuropathies. Part I.
    Stephanova DI; Daskalova M; Alexandrov AS
    Clin Neurophysiol; 2005 May; 116(5):1153-8. PubMed ID: 15826856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conduction slowing in diabetic distal polyneuropathy.
    Herrmann DN; Ferguson ML; Logigian EL
    Muscle Nerve; 2002 Aug; 26(2):232-7. PubMed ID: 12210388
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alteration of proximal conduction velocity at distal nerve injury in carpal tunnel syndrome: demyelinating versus axonal change.
    Chang MH; Liu LH; Lee YC; Hsieh PF
    J Clin Neurophysiol; 2008 Jun; 25(3):161-6. PubMed ID: 18469728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nerve conduction studies in polyneuropathy: practical physiology and patterns of abnormality.
    Franssen H; van den Bergh PY
    Acta Neurol Belg; 2006 Jun; 106(2):73-81. PubMed ID: 16898257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sensitivity of conventional motor nerve conduction examination in detecting patchy demyelination: a simulated model.
    Caliandro P; Stålberg E; La Torre G; Padua L
    Clin Neurophysiol; 2007 Jul; 118(7):1577-85. PubMed ID: 17524765
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conduction velocity distribution: early diagnostic tool for peripheral neuropathies.
    Kiziltan E; Dalkilic N; Guney FB; Pehlivan F
    Int J Neurosci; 2007 Feb; 117(2):203-13. PubMed ID: 17365108
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Compound action potentials of human sural nerve biopsies.
    Lambert EH; Dyck PJ
    Electroencephalogr Clin Neurophysiol; 1968 Oct; 25(4):399-400. PubMed ID: 4176575
    [No Abstract]   [Full Text] [Related]  

  • 54. Dispersion of compound muscle action potential in hereditary neuropathies and chronic inflammatory demyelinating polyneuropathy.
    Stanton M; Pannoni V; Lewis RA; Logigian EL; Naguib D; Shy ME; Cleland J; Herrmann DN
    Muscle Nerve; 2006 Oct; 34(4):417-22. PubMed ID: 16823858
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electrophysiology in demyelinating polyneuropathies.
    Franssen H
    Expert Rev Neurother; 2008 Mar; 8(3):417-31. PubMed ID: 18345972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathophysiology of multiple sclerosis and related clinical implications.
    Davis FA
    Mod Treat; 1970 Sep; 7(5):890-902. PubMed ID: 4933354
    [No Abstract]   [Full Text] [Related]  

  • 57. High-dose cyclophosphamide without stem cell rescue for refractory multifocal motor neuropathy.
    Brannagan TH; Alaedini A; Gladstone DE
    Muscle Nerve; 2006 Aug; 34(2):246-50. PubMed ID: 16502421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dynamic change of proximal conduction in demyelinating neuropathies: a cervical magnetic stimulation combined with maximum voluntary contraction.
    Hitomi T; Kaji R; Murase N; Kohara N; Mezaki T; Nodera H; Kawamura T; Ikeda A; Shibasaki H
    Clin Neurophysiol; 2007 Apr; 118(4):741-50. PubMed ID: 17317300
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Age-related changes in amplitude ratio, duration ratio and area ratio in nerve conduction studies].
    Kurokawa K; Tanaka E; Yamashita H; Nakayama T; Maruyama H; Yukawa M; Kohriyama T; Mimori Y; Nakamura S
    Nihon Ronen Igakkai Zasshi; 1995; 32(8-9):547-52. PubMed ID: 8531399
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amantadine restores impulse conduction across demyelinated nerve segments.
    Schauf CL
    Clin Exp Pharmacol Physiol; 1987 Apr; 14(4):273-81. PubMed ID: 3499273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.